Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.

Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E.

Osteoporos Int. 2013 Sep;24(9):2499-507. doi: 10.1007/s00198-013-2325-6. Epub 2013 Mar 23.

PMID:
23525894
[PubMed - indexed for MEDLINE]
2.

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.

Knapen MH, Schurgers LJ, Vermeer C.

Osteoporos Int. 2007 Jul;18(7):963-72. Epub 2007 Feb 8.

PMID:
17287908
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Emaus N, Gjesdal CG, Almås B, Christensen M, Grimsgaard AS, Berntsen GK, Salomonsen L, Fønnebø V.

Osteoporos Int. 2010 Oct;21(10):1731-40. doi: 10.1007/s00198-009-1126-4. Epub 2009 Nov 25.

PMID:
19937427
[PubMed - indexed for MEDLINE]
4.

Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.

Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R.

PLoS Med. 2008 Oct 14;5(10):e196. doi: 10.1371/journal.pmed.0050196. Erratum in: PLoS Med. 2008 Dec;5(12):e247.

PMID:
18922041
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects.

Theuwissen E, Cranenburg EC, Knapen MH, Magdeleyns EJ, Teunissen KJ, Schurgers LJ, Smit E, Vermeer C.

Br J Nutr. 2012 Nov 14;108(9):1652-7. doi: 10.1017/S0007114511007185. Epub 2012 Jan 31.

PMID:
22289649
[PubMed - indexed for MEDLINE]
6.

Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women.

Koitaya N, Ezaki J, Nishimuta M, Yamauchi J, Hashizume E, Morishita K, Miyachi M, Sasaki S, Ishimi Y.

J Nutr Sci Vitaminol (Tokyo). 2009 Feb;55(1):15-21.

PMID:
19352059
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.

Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20.

PMID:
19153678
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.

Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W, Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, Wu Q, Zhao SJ.

Osteoporos Int. 2012 Apr;23(4):1317-27. doi: 10.1007/s00198-011-1577-2. Epub 2011 Apr 20.

PMID:
21505910
[PubMed - indexed for MEDLINE]
9.

The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children.

van Summeren MJ, Braam LA, Lilien MR, Schurgers LJ, Kuis W, Vermeer C.

Br J Nutr. 2009 Oct;102(8):1171-8. doi: 10.1017/S0007114509382100. Epub 2009 May 19.

PMID:
19450370
[PubMed - indexed for MEDLINE]
10.

Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.

Palomba S, Orio F Jr, Manguso F, Falbo A, Russo T, Tolino A, Tauchmanovà L, Colao A, Doldo P, Mastrantonio P, Zullo F.

Osteoporos Int. 2005 Sep;16(9):1141-9. Epub 2005 Jun 1.

PMID:
15928801
[PubMed - indexed for MEDLINE]
11.

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.

Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruyère O, Roux C.

Osteoporos Int. 2012 Mar;23(3):1115-22. doi: 10.1007/s00198-011-1847-z. Epub 2011 Nov 29.

PMID:
22124575
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.

Mok CC, Ying KY, To CH, Ho LY, Yu KL, Lee HK, Ma KM.

Ann Rheum Dis. 2011 May;70(5):778-84. doi: 10.1136/ard.2010.143453. Epub 2010 Dec 27.

PMID:
21187295
[PubMed - indexed for MEDLINE]
13.

Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.

Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, Checovich M, Chappell R, Suttie J.

J Bone Miner Res. 2009 Jun;24(6):983-91. doi: 10.1359/jbmr.081254.

PMID:
19113922
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.

Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C.

Calcif Tissue Int. 2003 Jul;73(1):21-6.

PMID:
14506950
[PubMed - indexed for MEDLINE]
15.

Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin.

Tsugawa N, Shiraki M, Suhara Y, Kamao M, Tanaka K, Okano T.

Am J Clin Nutr. 2006 Feb;83(2):380-6.

PMID:
16469998
[PubMed - indexed for MEDLINE]
Free Article
16.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
17.

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.

McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH 3rd, Ensrud KE, Burdeska A, Mills T; Oral Ibandronate Study Group.

J Bone Miner Res. 2004 Jan;19(1):11-8.

PMID:
14753731
[PubMed - indexed for MEDLINE]
18.

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.

Cheung AM, Tile L, Cardew S, Pruthi S, Robbins J, Tomlinson G, Kapral MK, Khosla S, Majumdar S, Erlandson M, Scher J, Hu H, Demaras A, Lickley L, Bordeleau L, Elser C, Ingle J, Richardson H, Goss PE.

Lancet Oncol. 2012 Mar;13(3):275-84. doi: 10.1016/S1470-2045(11)70389-8. Epub 2012 Feb 7.

PMID:
22318095
[PubMed - indexed for MEDLINE]
19.

Fracture risk remains reduced one year after discontinuation of risedronate.

Watts NB, Chines A, Olszynski WP, McKeever CD, McClung MR, Zhou X, Grauer A.

Osteoporos Int. 2008 Mar;19(3):365-72. Epub 2007 Oct 16.

PMID:
17938986
[PubMed - indexed for MEDLINE]
20.

Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin.

Schaafsma A, Muskiet FA, Storm H, Hofstede GJ, Pakan I, Van der Veer E.

Eur J Clin Nutr. 2000 Aug;54(8):626-31.

PMID:
10951511
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk